tirzepatide vision Weight-loss drugs like semaglutide and linked to rare loss condition Semaglutide or Tirzepatide and Optic

Persistence at 360 days was significantly higher for semaglutide QW (67.0%) versus dulaglutide (56.0%), liraglutide (40.4%), and exenatide QW (35.5%)

Learn safety risks, timing tips, and when to check with our medical team today.

Total CBD & CBN & THC

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

We now have a NICE-funded route to semaglutide 2.4 mg for secondary CV prevention, alongside standard care, a reduced-calorie diet and increased physical activity, and not dependent on diabetes or Tier 3 weight-management eligibility